Allogene Therapeutics, Inc.·4

Mar 25, 5:49 PM ET

Bhavnagri Veer 4

4 · Allogene Therapeutics, Inc. · Filed Mar 25, 2022

Insider Transaction Report

Form 4
Period: 2022-03-23
Bhavnagri Veer
General Counsel
Transactions
  • Award

    Common Stock

    2022-03-23+175,438589,279 total
  • Award

    Stock Option (Right to Buy)

    2022-03-23+272,435272,435 total
    Exercise: $9.69Exp: 2032-03-23Common Stock (272,435 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter

Documents

1 file
  • 4
    marketforms-55857.xmlPrimary

    PRIMARY DOCUMENT